Charles W. Newhall III

Insider Reports History

Entity
Individual
Location
1119 St Paul St, Baltimore, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles W. Newhall III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 136K $5.39M $39.70 Feb 22, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 4.48K $178K $39.70 Feb 19, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $39.70 Feb 22, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 7.3K Feb 19, 2025 Direct

Insider Reports Filed by Charles W. Newhall III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2025 2 $0 4 Feb 24, 2025 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2025 2 $0 4 Feb 21, 2025 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 11, 2024 3 -$205K 4 Nov 12, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 2 $0 4 Feb 27, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 2 $0 4 Feb 26, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 16, 2023 3 -$1.12K 4 Nov 20, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 31, 2022 1 $0 5 Feb 8, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 28, 2022 2 $68.9K 4 Dec 30, 2022 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4 Feb 24, 2022 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2022 2 $0 4 Feb 23, 2022 Director